2020
Association of lymph node count and survival after primary retroperitoneal lymph node dissection (RPLND) for testicular nonseminomatous germ cell tumor (NSGCT).
Patel H, Srivastava A, Kim S, Singer E, Kim I, Jang T. Association of lymph node count and survival after primary retroperitoneal lymph node dissection (RPLND) for testicular nonseminomatous germ cell tumor (NSGCT). Journal Of Clinical Oncology 2020, 38: e17052-e17052. DOI: 10.1200/jco.2020.38.15_suppl.e17052.Peer-Reviewed Original ResearchNonseminomatous germ cell tumorsRetroperitoneal lymph node dissectionLymph node countOverall survivalLN countStage IPrimary retroperitoneal lymph node dissectionTesticular nonseminomatous germ cell tumorsMultivariate analysisClinical stage ILymph node dissectionNational Cancer DatabaseSingle-center studyKaplan-Meier methodGerm cell tumorsNode countPT2 diseaseNode dissectionAnalytic cohortFavorable survivalCenter studyCell tumorsCancer DatabaseTherapeutic implicationsAcademic centers
2019
Treatment disparities among patients in the National Cancer Database (NCDB) with clinical TIa and TIb renal masses.
Sterling J, Rivera-Nunez Z, Farber N, Modi P, Radadia K, Kim S, Sharad G, Rahul P, Weiss R, Kim I, Elsamra S, Jang T, Singer E. Treatment disparities among patients in the National Cancer Database (NCDB) with clinical TIa and TIb renal masses. Journal Of Clinical Oncology 2019, 37: 648-648. DOI: 10.1200/jco.2019.37.7_suppl.648.Peer-Reviewed Original ResearchRenal cell carcinomaNational Cancer DatabaseCT1b patientsPartial nephrectomyCT1a patientsOpen procedureAcademic centersCT1 renal cell carcinomaUtilization of PNPrivate insuranceClinical T1a tumorsPatterns of careLower household incomeLogistic regression modelsCT1a tumorsCT1b tumorsRCC surgeryT1a tumorsClinical characteristicsCT1 tumorsT1b tumorsTreatment disparitiesImpact of regionalizationCell carcinomaAUA guidelines